ClinicalTrials.Veeva

Menu

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine

G

Gynuity Health Projects

Status

Completed

Conditions

Other Abortion

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Ukraine.

Enrollment

172 patients

Sex

Female

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Having an ongoing pregnancy of 13-22 weeks gestation
  • Be willing to undergo surgical completion if necessary
  • Have no contraindications to study procedures, according to provider
  • Be willing and able to consent to participate in the study
  • Be willing to follow study procedures

Exclusion criteria

  • Known allergy to mifepristone or misoprostol/prostaglandin
  • Any contraindications to vaginal delivery, including placenta previa
  • Unable to provide consent

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems